Sprint Bioscience
PublicSprint Bioscience is now publicly traded
The data on this page reflects Sprint Bioscience's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Follow-on Offering
Apr 28, 2025
Total Funding Raised
$27.01M
Company Overview
Sprint Bioscience has raised $27.01M. It was founded in 2009.
Sprint Bioscience AB is a Swedish pharmaceutical company that specializes in the preclinical development of small-molecule drug candidates, with a primary focus on oncology. Founded in 2009, the company operates on a business model of developing novel cancer therapies from idea to drug candidate and then out-licensing these programs to larger global pharmaceutical companies for further clinical development and commercialization. Sprint Bioscience utilizes a fragment-based drug discovery (FBDD) platform to accelerate the identification of suitable molecules. The company is publicly traded on the Nasdaq First North Premier Growth Market in Stockholm.
AI Layer
Non-AI
Sprint Bioscience Comparables
Compare Sprint Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beactica Therapeutics | 83% | |
| L-Base | 69% | |
| Global Cancer Technology, Inc. | 60% |
For institutional investors. Book with your work email.
Sprint Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Apr 28, 2025 | ||||
| Follow-on Offering | Nov 18, 2022 | ||||
| Follow-on Offering | Sep 2, 2021 | ||||
| Convertible Debt | Jun 30, 2021 | ||||
| Private Placement | Apr 8, 2021 | ||||
Follow-on Offering | Jun 22, 2020 |
For institutional investors. Book with your work email.
Sprint Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Första Entreprenörsfonden | Series A, Seed |
| Almi Invest AB | Series A, Seed |
| FE fonden | Series A |
| First Venture Sweden AB | Convertible Debt |
| Life Science Invest Fund 1 | Follow-on Offering |
Sprint Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.